ImmunityBio, Inc. (IBRX)

8.075 -0.12 (-1.40%) USD  |  NASDAQ  |  Sep 04, 16:00
8.08 0.00 (0.00%) After-Hours: 18:22
More

ImmunityBio Cash and Short Term Investments (Annual) : 242.82M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for IBRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2013. Start Trial.
Date Value
December 31, 2025 242.82M
December 31, 2024 149.81M
December 31, 2023 266.46M
December 31, 2022 107.18M
December 31, 2021 317.12M
December 31, 2020 66.21M
December 31, 2019 51.65M
Date Value
December 31, 2018 74.15M
December 31, 2017 128.15M
December 31, 2016 198.92M
December 31, 2015 294.22M
December 31, 2014 59.10M
December 31, 2013 0.35M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Moderna, Inc. 5.80B
Sarepta Therapeutics, Inc. 939.65M
Arrowhead Pharmaceuticals, Inc. 919.37M
Oncolytics Biotech, Inc. 5.202M
Sangamo Therapeutics, Inc. 20.95M